MustGrow Biologics Corp.
MGROF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $34 | $43 | $54 | $69 |
| - Cash | $2 | $2 | $2 | $3 |
| + Debt | $1 | $3 | $3 | $1 |
| Enterprise Value | $32 | $44 | $55 | $66 |
| Revenue | $1 | $3 | $4 | $0 |
| % Growth | -72.3% | -24.7% | 3,082.5% | – |
| Gross Profit | $0 | $1 | $1 | $0 |
| % Margin | 17.9% | 20.9% | 14.3% | 21.3% |
| EBITDA | -$2 | -$1 | -$2 | -$0 |
| % Margin | -305% | -35.9% | -42% | -143.1% |
| Net Income | -$2 | -$1 | -$2 | -$1 |
| % Margin | -221% | -38.2% | -43.4% | -1,020.7% |
| EPS Diluted | -0.032 | -0.021 | -0.032 | -0.016 |
| % Growth | -52.6% | 34.3% | -95.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$4 | -$1 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$4 | -$1 |